- Home
- DYN vs JAMF Comparison
DYN vs JAMF Comparison
Compare DYN & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- JAMF
- Stock Information
- Founded
- DYN 1984
- JAMF 2002
- Country
- DYN United States
- JAMF United States
- Employees
- DYN N/A
- JAMF N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- JAMF Computer Software: Prepackaged Software
- Sector
- DYN Health Care
- JAMF Technology
- Exchange
- DYN Nasdaq
- JAMF Nasdaq
- Market Cap
- DYN 1.3B
- JAMF 1.5B
- IPO Year
- DYN 2020
- JAMF 2020
- Fundamental
- Price
- DYN $14.70
- JAMF $10.67
- Analyst Decision
- DYN Strong Buy
- JAMF Buy
- Analyst Count
- DYN 13
- JAMF 8
- Target Price
- DYN $45.92
- JAMF $19.63
- AVG Volume (30 Days)
- DYN 2.0M
- JAMF 844.5K
- Earning Date
- DYN 05-08-2025
- JAMF 05-06-2025
- Dividend Yield
- DYN N/A
- JAMF N/A
- EPS Growth
- DYN N/A
- JAMF N/A
- EPS
- DYN N/A
- JAMF N/A
- Revenue
- DYN N/A
- JAMF $642,897,000.00
- Revenue This Year
- DYN N/A
- JAMF $12.65
- Revenue Next Year
- DYN N/A
- JAMF $9.06
- P/E Ratio
- DYN N/A
- JAMF N/A
- Revenue Growth
- DYN N/A
- JAMF 10.75
- 52 Week Low
- DYN $6.36
- JAMF $9.95
- 52 Week High
- DYN $47.45
- JAMF $19.05
- Technical
- Relative Strength Index (RSI)
- DYN 72.20
- JAMF 44.79
- Support Level
- DYN $13.14
- JAMF $10.51
- Resistance Level
- DYN $12.34
- JAMF $10.90
- Average True Range (ATR)
- DYN 0.79
- JAMF 0.28
- MACD
- DYN 0.23
- JAMF 0.02
- Stochastic Oscillator
- DYN 91.82
- JAMF 41.87
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About JAMF Jamf Holding Corp.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.